Nanobiotix (NBTX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Nanobiotix (NBTX) is Neutral.

The composite score behind that read is -0.13, weighing +0.18 of bullish evidence against -0.25 bearish.

Nanobiotix last closed at $23.68, +3.41% on the session.

Against the IVW growth benchmark the position is +2.61% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

Nanobiotix has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

Nanobiotix is classified under Health Care / Biotechnology, with a market capitalisation of $1.11B.

StockMap tracks Nanobiotix as the 128th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Nanobiotix ranks 258th of 381 in the group, against a group median of -0.08.